Next Article in Journal
Structural Basis of Membrane Trafficking by Rab Family Small G Protein
Next Article in Special Issue
Biomarkers for Anti-Angiogenic Therapy in Cancer
Previous Article in Journal
Triterpenoids from the Roots of Rhaphiolepis indica var. tashiroi and Their Anti-Inflammatory Activity
Previous Article in Special Issue
MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1α (HIF-1α) in Prostate Cancer Cells
Int. J. Mol. Sci. 2013, 14(5), 8899-8911; doi:10.3390/ijms14058899
Article

Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform

1,* , 1
, 1
, 2
, 2
, 3
, 1
 and 1,*
Received: 5 March 2013; in revised form: 8 April 2013 / Accepted: 18 April 2013 / Published: 24 April 2013
(This article belongs to the Special Issue Advances in Cancer Diagnosis)
View Full-Text   |   Download PDF [450 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Epidemiological studies indicated that esophageal squamous-cell carcinoma (ESCC) is still one of the most common causes of cancer incidence in the world. Searching for valuable markers including circulating endogenous metabolites associated with the risk of esophageal cancer, is extremely important A comparative metabolomics study was performed by using ultraperformance liquid chromatography-electrospray ionization-accurate mass time-of-flight mass spectrometry to analyze 53 pairs of plasma samples from ESCC patients and healthy controls recruited in Huaian, China. The result identified a metabolomic profiling of plasma including 25 upregulated metabolites and five downregulated metabolites, for early diagnosis of ESCC. With a database-based verification protocol, 11 molecules were identified, and six upregulated molecules of interest in ESCC were found to belong to phospholipids as follows: phosphatidylserine, phosphatidic acid, phosphatidyl choline, phosphatidylinositol, phosphatidyl ethanolamine, and sphinganine 1-phosphate. Clinical estimation of metabolic biomarkers through hierarchical cluster analysis in plasma samples from 17 ESCC patients and 29 healthy volunteers indicated that the present metabolite profile could distinguish ESCC patients from healthy individuals. The cluster of aberrant expression of these metabolites in ESCC indicates the critical role of phospholipid metabolism in the oncogenesis of ESCC and suggests its potential ability to assess the risk of ESCC development in addition to currently used risk factors.
Keywords: metabolomics; plasma; esophageal squamous-cell carcinoma; UPLC/TOF/MS metabolomics; plasma; esophageal squamous-cell carcinoma; UPLC/TOF/MS
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Liu, R.; Peng, Y.; Li, X.; Wang, Y.; Pan, E.; Guo, W.; Pu, Y.; Yin, L. Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform. Int. J. Mol. Sci. 2013, 14, 8899-8911.

AMA Style

Liu R, Peng Y, Li X, Wang Y, Pan E, Guo W, Pu Y, Yin L. Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform. International Journal of Molecular Sciences. 2013; 14(5):8899-8911.

Chicago/Turabian Style

Liu, Ran; Peng, Yuan; Li, Xiaobo; Wang, Yi; Pan, Enchun; Guo, Wei; Pu, Yuepu; Yin, Lihong. 2013. "Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform." Int. J. Mol. Sci. 14, no. 5: 8899-8911.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert